Robert Thomas Keenan MD MPH, MBA
Crystal Related, Spondyloarthropathy, Vasculitis
Adjunct Associate Professor, Medicine, Duke University School of Medicine
Join to View Full Profile
800 E. Cheves St.Suite 280Florence, SC 29506
Phone+1 843-973-8770
Fax+1 843-428-2490
Dr. Keenan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of MassachusettsMBA, 2014 - 2017
NYU Grossman School of MedicineFellowship, Rheumatology, 2007 - 2009
SSM Health/Saint Louis University School of MedicineResidency, Internal Medicine, 2004 - 2007
St. George's University School of MedicineClass of 2004- University of North Carolina at Chapel HillMPH, 1998 - 2000
Certifications & Licensure
NC State Medical License 2009 - 2025
SC State Medical License 2020 - 2025
NY State Medical License 2007 - 2009
VA State Medical License 2007 - 2008
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Fellow (FACR) American College of Rheumatology
Publications & Presentations
PubMed
- 7 citationsThe COMPARE head-to-head, randomized controlled trial of SEL-212 (pegadricase plus rapamycin-containing nanoparticle, ImmTOR™) versus pegloticase for refractory gout.Herbert S B Baraf, Puja P Khanna, Alan J Kivitz, Vibeke Strand, Hyon K Choi
Rheumatology. 2024-04-02 - 2 citationsPegloticase causes prolonged improvement in multiple disease parameters in patients with chronic refractory gout who maintain low serum urate levels.Robert T Keenan, Anthony E Yeo, Peter E Lipsky
Clinical and Experimental Rheumatology. 2022-05-01 - 4 citationsExpert Opinion on Pegloticase with Concomitant Immunomodulatory Therapy in the Treatment of Uncontrolled Gout to Improve Efficacy, Safety, and Durability of Response.John K Botson, Herbert S B Baraf, Robert T Keenan, John Albert, Karim R Masri
Current Rheumatology Reports. 2022-01-01
Press Mentions
12 Myths About Gout That You Should Stop Believing NowMay 21st, 2021- Clinician Q&A: Can Immunomodulators Improve the Effect of Pegloticase in Uncontrolled Gout?April 2nd, 2021
What Is a Good Diet for Gout That Will Reduce Your Risk of Painful Flare-UpsFebruary 24th, 2020
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
